Events

TIAFT joint session with IATDMCT. Martinique, June 6, 2008

AACC-IATDMCT Joint Symposium LC/MS and LC MS/MS in Clinical and Forensic Toxicology, Jul 26, 2008 Registration form



 

International Conference Therapeutic drug monitoring in optimizing immunosuppressive therapy. Warsaw, Poland, September 26-27, 2008

Login

Forgot Password

Our aims are:

  • To promote the knowledge and understanding of clinical drug analysis and interpretation of results.

 

  • To enhance communication between scientists and physicians of all disciplines involved in therapeutic drug monitoring and clinical toxicology.

 

  • To encourage the effective application of therapeutic drug monitoring and clinical toxicology; with the aim of optimizing clinical drug use and maximizing the clinical and economic benefits.

 

Application form (PDF) (Word)

Journal

IATDMCT is assuming ownership of Therapeutic Drug Monitoring journal

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

Deuterated Internal Standards

DEUTERATED INTERNAL STANDARDS DONATED BY NOVARTIS

IATDMCT is pleased to announce that Novartis Pharma have generously made a gift of deuterated ciclosporin and everolimus for use as internal standards in HPLC mass-spectrometric assays. The compounds are available to laboratories providing a TDM service for either of these drugs and will be supplied if there is at least one IATDMCT member in good standing within the laboratory. To obtain these compounds you will need to sign a material transfer agreement, supply details of the number of samples you analyse per year, details of the proficiency testing scheme to which you subscribe and IATDMCT membership details. You will only pay the delivery costs and costs associated with administration of the service.

To apply for these compounds please contact Prof. David W Holt at dwhasil@aol.com .

Powered By Dragonfly IT Ltd.